The first 100 days in office sets the tone for any new president. Similarly, Motley Fool CAPS keeps an eye on how well investors do in their first 100 days. Some of our best -- we call them All-Stars -- have achieved scores of 100 on stock selections in their first days on CAPS. In this column, we're looking at our best players who made some of their best selections early on and seeing which stocks they think will be best next.

One of our highest-rated CAPS members is Gtrinvestor, with a 99.98 member rating. A member since November 2006, Gtrinvestor now has 92 active picks on CAPS out of almost 1,000 stock picks made. While achieving 83% accuracy, Gtrinvestor has attracted 405 "groupies" -- CAPS players who've listed this investor as one of their favorites.

Here are a few of this member's most recent stock selections and how they were rated.


CAPS Rating  (5 max)



Current Score

AstraZeneca (NYSE:AZN)





Borders Group (NYSE:BGP)





Endeavor Power





Nam Tai Electronics (NYSE:NTE)





NYSE Euronext (NYSE:NYX)





Pharmaceutical Product Development (NASDAQ:PPDI)





SkyTerra Communications





Switch & Data Facilities (NASDAQ:SDXC)





Under Armour (NYSE:UA)





Source: Motley Fool CAPS; *Price when call was made. Current score is how many points by which a member is beating (lagging) the S&P 500 index from the time of the call.

Let's take a look at what other CAPS members are saying about some of these stocks and whether they agree with this member's assessment.

Degree of risk
The books might look the same lined up in neat rows on the shelves, but Borders Group is undergoing a massive overhaul. Senior managers were swapped out and there's a new executive who specializes in turnarounds, while the board of directors itself will include a raft of new faces.

Not all investors think the new management team will succeed. CAPS All-Star tenmiles says he's not sold on the changes.

Turning the page on Borders after recent run, as not confident Ron Marshall can work the magic on this one. Company is trying to improve its inventory efficiency, but with sales declines, competitive pressures and ugly debt/equity profile, not convinced it will survive. Chapter 11 reorg under business, non-fiction section could easily be in the cards in 2010.

Even exchange
Regulators are hoping to protect investors trading derivatives in case of a collapse like the one with Lehman Brothers by forcing them to clear trades through one of the five central clearinghouses. Then they could reclaim collateral for contracts cleared. The discussion has been helping those clearinghouses, especially NYSE Euronext, because clearing the contracts would force dealers to engage with all of them, thus promoting competition. And NYSE Euronext should pick up revenue.

Another All-Star, TMFKopp, admits there's a lot of uncertainty surrounding the exchange, but that the long-term opportunities outweigh that risk.

Like elsewhere, lots of question marks in the near term, but I like the potential for the company to continue to develop, grow, and change with the financial industry and continue to be a leader in the exchange industry.

A 1-in-100 opportunity
Some of the best and smartest members in the CAPS investor intelligence community have made their mark. It pays to start your own research on these stocks on Motley Fool CAPS. Read a company's financial reports, scrutinize key data and charts, and examine the comments your fellow investors have made -- all from a stock's CAPS page.

As hockey great Wayne Gretzky once noted, "You miss 100% of the shots you never take." At Motley Fool CAPS, every investor's opinion counts. It's free to sign up, so why not use this opportunity to take your best shot?

NYSE Euronext and Under Armour are Motley Fool Rule Breakers recommendations. Pharmaceutical Product Development is a Stock Advisor recommendation. Nam Tai Electronics is a Global Gains selection. Under Armour is a Motley Fool Hidden Gems pick, and the Fool owns shares of Under Armour. Try any of our Foolish newsletters today, free for 30 days.

Fool contributor Rich Duprey does not have a financial position in any of the stocks mentioned in this article. You can see his holdings. The Motley Fool has a disclosure policy.